Emil  Hedberg

Emil Hedberg

Partner, Stockholm Download CV Download vCard

Emil works in Schjødt's Finance & Capital Markets department. He specialises in securities law, capital markets transactions, public M&A and general corporate advisory. Emil has extensive experience in Swedish and international transactions and advises issuers as well as investment banks, private equity sponsors and other market participants. He also has experience in incentive schemes, market abuse regulation and other financial regulation for listed companies. 

Emil joined the firm in 2020 in connection with Schjødt's merger with the Swedish law firm Hamilton. Prior to that, he practiced as a lawyer with the law firms Roschier and Vinge. He holds an LL.M. and an M.Sc. in Business Administration from Stockholm University. Emil has also lectured on equity capital markets law at the Gothenburg School of Business, Economics and Law.

Practice areas

Emil Hedberg has a high knowledge of the subject. What makes him stand out is his availability and solutions-based point of view. Legal 500

About Emil

Experience

  • Partner in charge of several IPOs
  • Partner in charge of several public tender offers
  • Partner in charge of several rights issues and private placements
  • Partner in charge of legal mergers of listed companies
  • Chaired more than 30 shareholders' meetings in listed companies

Rankings

  • 2020

    Next Generation Partners and Recommended - Legal 500

Education

  • 2007

    Master of Laws (LL.M.), Stockholm University

  • 2007

    M.Sc. in Business Administration, Stockholm University

References

  • Partner in charge:acted for Karo Pharma in connection with EQT's public tender offer for Karo Pharma
  • Partner in charge:acted for Karessa Pharma in connection with the legal merger with Klaria Pharma
  • Partner in charge:acted for a consortium of investors in connection with their investment in Klarna
  • Partner in charge:acted for Smart Start in connection with its public tender offer for Dignita
  • Partner in charge:acted for Bio-Works Technologies in connection with its IPO